BiVictriX Therapeutics Plc (BVX.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In GBp
Address
Bio Hub
Macclesfield, SK10 4TG
United Kingdom of Great Britain and Northern Ireland (the)
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
17
First IPO Date
August 11, 2021
| Name | Title | Pay | Year Born |
| Tiffany Jane Thorn | Chief Executive Officer & Executive Director | 226,375 | 1987 |
| Adrian Howd | Chief Business Officer & Chief Financial Officer | 0 | 1971 |
| Alison Halsall Lindsay | Secretary | 0 | N/A |
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.